telomeres: a new psychobiomarker network on …...sahin et al, 2011, nature immunosenescence...
TRANSCRIPT
![Page 1: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/1.jpg)
1
Elissa Epel, Assoc Professor Dept of Psychiatry, UCSF
Telomeres: A new psychobiomarker Network on Biological Risk May 2, 2012
![Page 2: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/2.jpg)
Telomere Length Telomerase enzyme
![Page 3: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/3.jpg)
Disclosure
Co-‐founder in Telome Health, Inc., a company focused on measurement of telomere length
![Page 4: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/4.jpg)
Telomeres/Telomerase Links with disease and lifestyle Measurement
Roadmap
![Page 5: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/5.jpg)
Elizabeth Blackburn
![Page 6: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/6.jpg)
Cell proliferation and telomere shortening
Haber et al, NEJM, 1995
![Page 7: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/7.jpg)
Sahin et al, 2011, Nature
![Page 8: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/8.jpg)
Immunosenescence
(McElhaney & Effros, 2009)
Telomeres and Disease Prediction Progression Mortality
![Page 9: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/9.jpg)
Telomeres and Disease
CAD, Myocardial InfarcCon Diabetes Vascular demenCa Obesity, insulin resistance Alzheimers Osteoporosis Rheumatoid ArthriCs Cancer
Samani et al, Lancet, 2001; Brouilette et al, 2003; Arterioscler Thromb Vasc Biol 2003; Sampson, 2006, Diabetes Care; von Zglinicki, 2000, Lab Invest. Jeanclos et al, 2000, Hypertension; Valdes et al, . Lancet 2005; Gardner, 2005, Circulation; Konig, 2006; Cawthon, 2003, Lancet.
![Page 10: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/10.jpg)
TL and cancer TL and cardiovascular diseases and risks
TL & mental health &
degenerative conditions
Terry et al., 2012 Liu et al., 2009 Bjorck et al., 2011 Farzaneh-Far et al., 2008 Devore et al., 2011
Arbeev et al., 2011 Rossi et al., 2009 Calvert et al., 2011 O’Donnell et al., 2008 Elvsashagen et al., 2011
Borssen et al., 2011 Shen et al., 2009 Dei Cas et al., 2011 Starr et al., 2008 Hochstrasser et al., 2011
Capezzone et al., 2011 Svenson et al., 2009 Fitzpatrick et al., 2011 Vasan et al., 2008 O’Donovan et al., 2011
Gu et al., 2011 Svenson et al., 2008 Fyhrquist et al., 2011 Adaikalakoteswari et al., 2007
Rius-Ottenheim et al., 2011
Hoffmann et al., 2011 Joshua et al., 2007 Houben et al., 2011 Bekaert et al., 2007 Takata et al., 2011
Jendrzejewski et al., 2011 McGrath et al., 2007 Krauss et al., 2011 Brouilette et al., 2007 Watfa et al., 2011
Kim et al., 2011 Shao et al., 2007 Kroenke et al., 2011 Collerton et al., 2007 Wolkowitz et al., 2011
Kuhn et al., 2011 Shen at al., 2007 Ragno et al., 2011 Fitzpatrick et al., 2007 Eerola et al., 2010
Liang et al., 2011 Broberg et al., 2005 Solorio et al., 2011 Van der Harst et al., 2007 Harris et al., 2010
Lu et al., 2011 Wu et al., 2003 Strandberg et al., 2011 Aviv et al., 2006 Hartmann et al., 2010
Martinez-Delgado et al., 2011
Wang et al., 2011 Demissie et al., 2006 Kananen et al., 2010
Mirabello et al., 2011 Weischer et al., 2011 Sampson et al., 2006 Mather et al., 2010
Nan et al., 2011 Wong et al., 2011 Gardner et al., 2005 Mather et al., 2010
Rampazzo et al., 2011 Yan et al., 2011 Valdes et al., 2005 Zekry et al., 2010
Shen et al., 2011 Kuznetsova et al., 2010 Benetos et al., 2004 Fernandez-Egea et al. 2009
Valls et al., 2011 Willeit et al., 2010 Brouilette et al., 2003 Grodstein et al., 2008
Prescott et al., 2010 Chen et al., 2009 Cawthon et al., 2003 Valdes et al., 2008
Willeit et al., 2010 Olivieri et al., 2009 Samani et al., 2001 Harris et al., 2006
Zheng et al., 2010 Yang et al., 2009 Jeanclos et al., 2000 Honig et al., 2006
De Vivo et al., 2009 Zee et al., 2009
Hosgood et al., 2009 Zee et al., 2009
![Page 11: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/11.jpg)
Copyright restrictions may apply.!
Willeit, P. et al. JAMA 2010;304:69-75.
Cumulative Cancer Incidence and Cancer Mortality Between 1995 and 2005 in the Bruneck Study
![Page 12: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/12.jpg)
Telomere Length predicts healthspan and longevity (8 studies)
Longer telomeres: increased years of healthy life (Njajou, 2009)
Shorter telomeres: Lower 17-‐year survival from aggregate of all causes (infecCous, CVD) (Cawthon, 2003)
Lower 10 year survival (Erlenbach, 2009) Lower 12 year survival in women (Epel, 2009) CAD paCents (4.4 years) (Farzaneh-‐Far, 2008) Alzheimers paCents (Honig, 2006) Twin studies (Baykasa, 2007; Kimura, 2008)
![Page 13: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/13.jpg)
Telomeres can lengthen!
This opens the door for identifying malleable determinants of rate of change
Telomeres lengthen in ~1/4th of adults (MacArthur Aging Study, analysis of high functioning 70 – 79 year olds)
Epel et al, Aging, 2009
![Page 14: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/14.jpg)
Life adversity, distress, and TL
• Perceived stress (Epel et al, 2004, Parks et al, 2009; Puterman 2010)
• Caregiver stress (Damjanovic, 2006; O’Donovan, 2011)
• Major Depression (Simon, 2006; Wolkowitz, 2011)
• PTSD (O’Donovan, 2011) • Former DomesCc Abuse vicCm • (length of abuse) (Humphreys et al, 2011)
• Early life trauma (Tyrka, 2010, Kiecolt Glaser, 2011, Surtees, 2011)
![Page 15: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/15.jpg)
TL is associated with lifestyle
Smoking Obesity, insulin resistance (Chronic, cycling), Kim et al, 2009)
Exercise (Cherkas et al, 2006; Werner et al, 2009, Mirabello et al, 2009)
Omega 3s in the blood (Farzaneh-‐Far et al, 2010)
Vitamins from supplements and food (Xu et al, 2009; Mirabello et al, 2009)
![Page 16: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/16.jpg)
Don’t expect main effects! Exercise and telomere length
![Page 17: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/17.jpg)
Lifespan View of Telomeres
Puterman & Epel, in press
![Page 18: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/18.jpg)
Summary Telomere length
§ Correlated with, and predicts diseases of aging § In several studies, predicts earlier mortality
§ Correlated with stress, psychological disorders, lifestyle factors § IntervenCons –may prevent shortening
§ Mechanism and/or marker § “MulCfinality” not “unifinality” -‐-‐Reflects
mulCple inputs! § Weaker inferences, not ‘stress’
§ Predicts mulCple outcomes—not specific § Powerful in predicCng aging related outcomes
![Page 19: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/19.jpg)
METHODOLOGY "PROMISES & PITFALLS
![Page 20: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/20.jpg)
• Need cells, which have DNA (not plasma or serum)
• Blood draw is best! • Whole blood vs. PBMCs
• Other methods under validation: • Blood spot • Saliva (immune cells)
• Need special collection device (Genotek, Oragene)
• Buccal cells – meaning?
:
Measurement: Sample
![Page 21: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/21.jpg)
• Subject in good health? • Standardized time of day if possible • Relaxed conditions (stress mobilizes cells) • • Technical details: ACD tubes (yellow top, 6ml, Cat # 364816 from BD).
• Invert 30-‐40 Cmes • Pipene into 1ml screw cap tubes (cat# SRS-‐72-‐694-‐006 from Sardstedt) –use this!
• Store blood at -‐80°C • (can be at room temp fo 24hr).
:
Measurement: Collection
![Page 22: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/22.jpg)
1. Reliable assay -‐PCR vs. Southern Blot 2. Purity of DNA (eg, Qiagen gives great results, not
Puregene) 1. Store as blood if possible, over DNA
3. Make few assumpCons -‐Dogma is vast, data is scarce
4. Telomerase is reacCve (need resCng baselines)
:
Measurement: Assay & Interpretation
![Page 23: Telomeres: A new psychobiomarker Network on …...Sahin et al, 2011, Nature Immunosenescence (McElhaney & Effros, 2009) Telomeres and Disease Prediction Progression Mortality Telomeres](https://reader033.vdocuments.us/reader033/viewer/2022042322/5f0cb5d97e708231d436c064/html5/thumbnails/23.jpg)
1. Null results? 1. No relaConship with outcome 2. Inaccurate measure of TL (reliable & valid?) 3. Snap shot measure doesn’t capture trajectory of
change or telomerase level (stabilizes short telomeres)
4. May not maner as much during certain periods (older age)
2. Expect Complex relaConships (not main effects)
:
Measurement: Interpretation